课题基金 / 基金详情

Improving healthcare outcomes for cancer patients by increasing quality, safety and efficiency of IV Chemotherapy services

Improving healthcare outcomes for cancer patients by increasing quality, safety and efficiency of IV Chemotherapy services
通过提高静脉化疗服务的质量、安全性和效率来改善癌症患者的医疗保健结果
批准号:
102114
负责人:
金额:
$85.86万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该项目旨在为医院静脉化疗管理提供一个集成的数字平台。静脉化疗提供有许多危险。确保患者安全和质量至关重要。低效的订单管理、患者流、数据流、容量管理、质量和安全监测以及患者参与意味着这些服务价格昂贵,为患者提供劣质体验,并对患者构成安全风险。该平台将:1)管理和安排化疗订单的准备和管理,2)管理原材料的采购,3)根据良好生产规范(GMP)标准控制和审核药房和病房内静脉注射产品的配制,4)跟踪和追踪正确的静脉注射产品给正确的患者,5)监控废物的安全处理,6)让患者及其护理人员了解流程和时间表并提供反馈
英文摘要
The project aims to deliver an integrated digital platform for the management of IV Chemotherapy in hospital. IV Chemotherapy provision has many dangers. Ensuring patient safety & quality is critical. Inefficient order management, patient flow, data flow, capacity management, quality and safety monitoring and patient engagement has meant that these services are expensive, offer poor quality experience to patients and pose safety risks to patients. The platform will: 1) Manage & schedule the preparation and administration of Chemotherapy orders, 2) Manage purchase of raw materials, 3) control & audit the compounding of the IV product both in pharmacy & on the ward to Good Manufacturing Practice (GMP) standards, 4) Track & trace the correct IV product to the correct patient, 5) monitor the safe disposal of waste, 6) allow patients & their carers to have visibility of the process & schedule & provide feedback
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金